Navigation Links
VersaNail™

ProductsVersaNail™
Company DePuy Orthopaedics, Inc.
Item VersaNail™
Features 
  • Implant Versatility through design- Including options for Lateral-Medial or Posterior-Anterior distal screw orientation, three holes for anatomical distal locking, both a proximal locking static hole and dynamization slot, and a wide range of end cap and implant options
  • Instrumentation Versatility - Color coded instrumentation for ease of use, rotating targeting device enables 90° positions around the foot, an adjustable, stable proximal targeting carriage for nail length settings, intra-operative controlled proximal dynamization with the benefit of axial compression capabilities
    • Description The VersaNail System is a complete system of surgical instruments and implants for surgeons to use with TTC fusion surgery. The system was designed in consultation with orthopaedic specialists and integrates clinical research and engineering with advanced materials, techniques and anatomical design. Because every patient is different, and because the anatomy of the foot and ankle are very complex, the VersaNail System provides a range of implant sizes and instrument versatility, giving surgeons more choices for their patients.
    Info DePuy Orthopaedics, Inc.
    Customer Service: (800) 366-8143
    Web site: http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b9880772d01

    Related medicine products :

    1. Buechel-Pappas™ Total Ankle System
    2. Agility Total Ankle System
    3. Biomet® Ankle Arthrodesis Nail
    4. True/Fix Ankle Fusion Nail System
    5. Guhl Non-Invasive Ankle Distractor System
    6. Ankle Cryo/Cuff™
    7. Pediatric Ankle Cryo/Cuff™
    8. Air-Stirrup® Ankle Brace
    9. QualCare™ Compression Ankle Support
    10. Allsport Ankle Ortho II
    11. DarcoGel™ Ankle Brace
    ...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
    ...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
    ...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
    ...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
    Medicine Products:
    (Date:11/21/2008)...Call/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL )...gly approved the proposals submitted to them relat...cals Industries Ltd. (Nasdaq: TEVA ). , , ...ort of the transaction by the Barr shareholders," ... are pleased with the progress that we continue to...
    (Date:11/21/2008)...s cause remains a mysteryswept into Athens. The wa...oldiers and refugees of the war then raging betwee...s, social order broke down. Over the next three ye...third of its population. It lost the war too. The ...f the Golden Age of Greece. , The Plague of Ath...
    (Date:11/21/2008)...-- A prestigious group of physicians, nurses, and ...sburg, VA on March 27-29, 2009 at the Williamsburg... cutting-edge therapeutic protocols, novel diagnos...hat impact patient care. The full program, faculty...vailable at www.bioconferences.com/wh , , ...
    (Date:11/21/2008)...lent and smoking cessation less likely among perso...A.D.H.D.) In a study of smokers with attention de...ted elevated hyperactivity and impulsivity, with o...er 8 weeks than those with inattention symptoms al...tudy, now available online in Nicotine and Tobacc...
    Breaking Medicine News(10 mins):Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2
    ...the primary protein linked to soy allergies in chi.../. The two lines already are adapted to Illinois-l...seeking to produce new varieties of allergy-free s...ineering. Crop scientists at the University of Il...
    ...e receptor for Helicobacter pylori as the decay-ac...lial cells in the stomach//. Blocking this intera... of peptic ulcer disease or gastric cancer. The re...ek’ in the May 12 issue of the Journal of Biologic...
    ...lans for slow suffocation of millions of poultry, ... According to Compassion in World Farming (CIWF) ...ulations 1995 have been amended under emergency pr...has been authorized for "ventilation shutdown" as ...
    ...ted that the centralization of hospital services i...ong distances// to receive health care. The limita...n made glaringly evident. Patients and their rel...em a significant issue especially because commerci...
    Other Medicine News:Health News:Promise for Soya Allergy Sufferers 2Health News:Receptor for H.pylori Identified in Stomach 2
    (Date:11/20/2008).... 20 GlaxoSmithKline (NYS...Food and Drug Administration (FDA) granted acceler...e treatment of thrombocytopenia in patients with c...a (ITP) who have had an insufficient response to c...e approval is a significant milestone for PROMACTA...
    (Date:11/20/2008)...irstCall/ -- Bionovo, Inc.,(Nasdaq: BNVI ) anno...ase 1B,clinical trial of their lead drug candidat...at the Society for Integrative Oncology,s Fifth In...Company,s oral presentation was selected,as a top...of the Best of the,SIO Session on November 20, 20...
    (Date:11/20/2008)... PAREXEL International Corporation (Nasdaq: PRXL...ovider, today announced that it has opened an offi...and clinical research capabilities. With the addit...throughout five important biopharmaceutical center...Brazil, Chile, and Mexico. This expansion further ...
    (Date:11/19/2008)...ical significance , , ISELIN, N.J., Nov. 19...asdaq: PARS ) today announced results from its P... (NE) drug delivery technology formulated with 3% ...nter, randomized, double-blinded, placebo-controll...Company,s 3% Diclofenac Diethanolamine NanoEmulsio...
    Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2PAREXEL International to Present at Robert W Bairds 2008 Growth Stock Conference 19111 1PAREXEL International to Present at Robert W Bairds 2008 Growth Stock Conference 19111 2SEIU New Lawsuit 3A CNA Violated State Law in Mass Mailings to Iowa Nurses 19107 1SEIU New Lawsuit 3A CNA Violated State Law in Mass Mailings to Iowa Nurses 19107 2SEIU New Lawsuit 3A CNA Violated State Law in Mass Mailings to Iowa Nurses 19107 3Viagra May Protect Hearts of Some Muscular Dystrophy Patients 19105 1Viagra May Protect Hearts of Some Muscular Dystrophy Patients 19105 2Most Baby Boomers are Financially Unprepared for a Potential Disability 19101 1Most Baby Boomers are Financially Unprepared for a Potential Disability 19101 2
    ...ment of Type 2 Diabetes Presented at the,67th Annu...ation, SAN FRANCISCO, June 25, 2007 /PRNewswire/ -... company focused on the development,of therapeutic...,presentation of top line data of its phase 2a stu...sis Inhibitor for the treatment of,type 2 diabetes...
    ...E)--Jun 25, 2007 - Bentley,Pharmaceuticals, Inc. (...day announced positive clinical results in three,C...ug, Nasulin(TM),an intranasal insulin spray. The ...can Diabetes Association 67th Scientific,Sessions ...macokinetic study in,patients with type 1 diabetes...
    Other Medicine Technology:DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of,Improved Glycemic Control and Significant Reductions of,LDL-Cholesterol and C-Reactive Protein 2DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of,Improved Glycemic Control and Significant Reductions of,LDL-Cholesterol and C-Reactive Protein 3Bentley Reports Positive Results with Nasulin Intranasal Insulin,Spray at the American Diabetes Association Meeting 2Bentley Reports Positive Results with Nasulin Intranasal Insulin,Spray at the American Diabetes Association Meeting 3Bentley Reports Positive Results with Nasulin Intranasal Insulin,Spray at the American Diabetes Association Meeting 4Bentley Reports Positive Results with Nasulin Intranasal Insulin,Spray at the American Diabetes Association Meeting 5